ask="1.2900"
ask_size="1500"
average_daily_volume="105607"
bid="0.7000"
bid_size="200"
book_value="0.6940"
change="-0.0064"
change_from_200_day_moving_average="-0.2692"
change_from_50_day_moving_average="-0.0461"
change_from_52_week_high="-6.7664"
change_From_52_week_low="0.2634"
change_in_percent="-0.5378%"
close="1.1836"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.1560"
ebitda="-17.60M"
eps_estimate_current_year="-1.0900"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="-0.8200"
ex_dividend_date="N/A"
float_shares="7095000"
high="1.2000"
high_52_weeks="7.9500"
last_trade_date="2/22/2017"
last_trade_price="1.1836"
last_trade_size="1600"
last_trade_time="3:51pm"
low="1.1601"
low_52_weeks="0.9202"
market_capitalization="19.40M"
moving_average_200_day="1.4527"
moving_average_50_day="1.2297"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.0000"
open="1.1900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-18.5269%"
percent_change_from_50_day_moving_average="-3.7450%"
percent_change_from_52_week_high="-85.1120%"
percent_change_from_52_week_low="+28.6242%"
previous_close="1.1900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.7147"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.5900"
stock_exchange="NGM"
symbol="ORPN"
volume="15005"
weeks_range_52="0.9202 - 7.9500"
